Clinical studies recruiting near Giessen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
NA · University Hospital Gießen · Medical University Innsbruck · NCT05931783 Giessen Pulmonary Hypertension Registry and Biobank
Phase N/A · Department of Intermal Medicine - Universities of Giessen an · University of Giessen · NCT04145024 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Universitaetsklinikum Giessen und Marburg GmbH · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Takeda · NCT06747351 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Justus-Liebig-Universitaet Giessen · Princess Maxima Center for Pediatric Oncology · NCT05327894 Giessen Stroke Registry
Phase N/A · Universitätsklinikum Gießen · University of Giessen · NCT05295862 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · UKGM Gießen/Marburg · Pfizer · NCT06758401 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Universitätsklinikum Gießen · AGO Study Group · NCT05009082 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Universitaetsklinikum Giessen und Marburg GmbH · Pfizer · NCT07073820 Randomization of Single vs Multiple Arterial Grafts
NA · Giessen Hospital · Weill Medical College of Cornell University · NCT03217006 Topical Application of PRF Before Radiation Therapy
NA · University of Giessen · University of Giessen · NCT06406530 Endometrial Cancer Lymphadenectomy Trial
NA · Universitätsklinikum Gießen und Marburg GmbH, Frauenklinik · Philipps University Marburg · NCT03438474 Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening
Phase N/A · University Hospital Gießen and Marburg GmbH · Heidelberg University · NCT02270476 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Universitaetsklinikum Giessen und Marburg GmbH - Kinderherzz · Bayer · NCT07192952 A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects A
Phase 3 · Universitätsklinikum Gießen und Marburg GmbH, Zentrum fur Ki · Amicus Therapeutics · NCT04808505 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Universitätsklinikum Gießen und Marburg · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · UKGM Gießen/Marburg · Pfizer · NCT07144280 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinik der Justus-Liebig-Universität Gießen · Goethe University · NCT02872987 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Justus Liebig Universitat Gießen · AgNovos Healthcare, LLC · NCT04796350 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Universitätsklinikum Gießen und Marburg GmbH · Boehringer Ingelheim · NCT06531824 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Investigational Site Number : 2760003 · Sanofi · NCT06290128 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · UKGM Gießen/Marburg ( Site 1404) · Merck Sharp & Dohme LLC · NCT06623422 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · UKGM Studienzentrale · Taiho Oncology, Inc. · NCT05967689 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Universitaetsklinikum Giessen /ID# 252973 · AbbVie · NCT04928846 A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thro
Phase 3 · Universitaetsklinikum Giessen und Marburg GmbH · Janssen Research & Development, LLC · NCT06533098 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Fried
Phase 3 · UKGM - Universitätsklinikum Giessen und Marburg GmbH - Stand · Biogen · NCT06953583 Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure
NA · Justus Liebig University Giessen, University Hospital Giesse · University of Giessen · NCT06381427 A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combinati
Phase 2 · AbbVie · NCT07155174 A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Phase 3 · Universitätsklinikum Giessen und Marburg - Standort Giessen · Liquidia Technologies, Inc. · NCT07285655

Look up another city

Look up another condition